Actively Recruiting

Age: 20Years - 75Years
All Genders
Healthy Volunteers
NCT02118922

A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

Led by Massachusetts General Hospital · Updated on 2025-11-06

168

Participants Needed

1

Research Sites

691 weeks

Total Duration

On this page

Sponsors

M

Massachusetts General Hospital

Lead Sponsor

H

Harvard Medical School (HMS and HSDM)

Collaborating Sponsor

AI-Summary

What this Trial Is About

We have developed novel Brillouin microscopy and we are testing its potential for keratoconus and ectasia diagnostics. We plan to perform axial scans of the cornea in human volunteers in order to compare biomechanical properties of Keratoconus vs. Normal corneas and compare biomechanical properties of post-LASIK ectasia vs. normal corneas.

CONDITIONS

Official Title

A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

Who Can Participate

Age: 20Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy subjects with normal corneas, topography, and pachymetry
  • Patients diagnosed with mild, moderate, or advanced keratoconus based on topography and pachymetry
  • Healthy subjects who underwent uncomplicated LASIK surgery within the past 12 months with normal post-operative topography and pachymetry
  • Patients aged 20 to 60 years with post-LASIK ectasia diagnosed by topography, pachymetry, and clinical evaluation at least 12 months after LASIK
  • Patients diagnosed with myopia scheduled for PRK surgery without high astigmatism (> 2 diopters) or prior ocular surgeries
  • Myopic patients scheduled to receive LASIK surgery without high astigmatism (> 2 diopters) or prior ocular surgeries
  • Patients diagnosed with early, mild, or advanced stages of Fuchs' Endothelial Corneal Dystrophy, including those with or without keratoconus
Not Eligible

You will not qualify if you...

  • Patients with high astigmatism greater than 2 diopters
  • Patients with prior ocular surgeries other than those specified
  • Patients taking ocular medications except seasonal allergy medicine like ketotifen or artificial tears
  • Patients with occludable narrow angles without a patent peripheral iridotomy
  • Monocular subjects
  • Subjects unable to understand instructions for imaging procedures
  • Patients with corneal disorders other than keratoconus or Fuchs' dystrophy
  • Patients with history of ophthalmological surgeries that affect endothelial cell status, such as cataract surgeries

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

Loading map...

Research Team

F

Fatima Clouser, MS

CONTACT

A

Andy Yun, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

7

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here